Residual associations of inflammatory markers with eGFR after accounting for measured GFR in a community-based cohort without CKD

Clinical Journal of the American Society of Nephrology

Volumn 11, Issue 2, 2016, Pages 280-286

  Schei, Jørgen ^a,b   Stefansson, Vidar T N ^b   Mathisen, Ulla Dorte ^a,b   Eriksen, Bjørn O ^a,b   Solbu, Marit D ^a,b   Jenssen, Trond G ^b,c   Melsom, Toralf ^a,b  

^a UNIVERSITY HOSPITAL OF NORTH NORWAY   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

C reactive protein; Cardiovascular disease; Chronic kidney disease; Cystatin C; Fibrinogen; Glomerular filtration rate; Humans; Kidney function tests; Tumor necrosis factor

Indexed keywords

ALBUMIN; ANGIOTENSIN RECEPTOR ANTAGONIST; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CREATININE; CYSTATIN C; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IOHEXOL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 2; AUTACOID; CONTRAST MEDIUM; CST3 PROTEIN, HUMAN; TNFRSF1B PROTEIN, HUMAN; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADULT; ARTICLE; CHRONIC KIDNEY DISEASE; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; EXERCISE; FEMALE; GLOMERULUS FILTRATION RATE; HEART INFARCTION; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PROTEIN EXPRESSION; SPECTROPHOTOMETRY; SYSTOLIC BLOOD PRESSURE; TURBIDIMETRY; WAIST HIP RATIO; BIOLOGICAL MODEL; BLOOD; CROSS-SECTIONAL STUDY; KIDNEY; MIDDLE AGED; MULTIVARIATE ANALYSIS; NORWAY; PHYSIOLOGY; PREDICTIVE VALUE; REPRODUCIBILITY; STATISTICAL MODEL;

BIOMARKERS; C-REACTIVE PROTEIN; CONTRAST MEDIA; CREATININE; CROSS-SECTIONAL STUDIES; CYSTATIN C; FEMALE; FIBRINOGEN; GLOMERULAR FILTRATION RATE; HUMANS; INFLAMMATION MEDIATORS; IOHEXOL; KIDNEY; LINEAR MODELS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; MULTIVARIATE ANALYSIS; NORWAY; PREDICTIVE VALUE OF TESTS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; REPRODUCIBILITY OF RESULTS;

EID: 84957084008     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.07360715     Document Type: Article

References (30)

1. Levey AS, de Jong PE, Coresh J, ElNahas M, Astor BC, Matsushita K, Gansevoort RT, Kasiske BL, Eckardt KU: The definition, classification, and prognosis of chronic kidney disease: A KDIGO Controversies Conference report. Kidney Int 80: 17-28, 2011.
2. Shlipak MG, Matsushita K, Ärnlöv J, Inker LA, Katz R, Polkinghorne KR, Rothenbacher D, Sarnak MJ, Astor BC, Coresh J, Levey AS, Gansevoort RT; CKD Prognosis Consortium: Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med 369: 932-943, 2013.
3. Eriksen BO, Mathisen UD, Melsom T, Ingebretsen OC, Jenssen TG, Njølstad I, Solbu MD, Toft I: Cystatin C is not a better estimator of GFR than plasma creatinine in the general population. Kidney Int 78: 1305-1311, 2010.
4. Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, Kusek JW, Manzi J, Van Lente F, Zhang YL, Coresh J, Levey AS; CKD-EPI Investigators: Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 367: 20- 29, 2012.
5. Mathisen UD, Melsom T, Ingebretsen OC, Jenssen T, Njølstad I, Solbu MD, Toft I, Eriksen BO: Estimated GFR associates with cardiovascular risk factors independently of measured GFR. J Am Soc Nephrol 22: 927-937, 2011.
6. MelsomT, Fuskevåg OM,Mathisen UD, Strand H, Schei J, Jenssen T, Solbu M, Eriksen BO: Estimated GFR is biased by non-traditional cardiovascular risk factors. Am J Nephrol 41: 7-15, 2015.
7. Rule AD, Bailey KR, Lieske JC, Peyser PA, Turner ST: Estimating the glomerular filtration rate from serum creatinine is better than fromcystatin C for evaluating risk factors associated with chronic kidney disease. Kidney Int 83: 1169-1176, 2013.
8. Keller CR,Odden MC, Fried LF, NewmanAB, Angleman S, Green CA, Cummings SR, Harris TB, Shlipak MG: Kidney function and markers of inflammation in elderly persons without chronic kidney disease: The health, aging, and body composition study. Kidney Int 71: 239-244, 2007.
9. Danesh J, Wheeler JG, Hirschfield GM, Eda S, Eiriksdottir G, Rumley A, Lowe GD, Pepys MB, Gudnason V: C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350: 1387-1397, 2004.
10. Schnabel RB, Yin X, Larson MG, Yamamoto JF, Fontes JD, Kathiresan S, Rong J, LevyD, Keaney JF Jr.,Wang TJ, Murabito JM, Vasan RS, Benjamin EJ: Multiple inflammatory biomarkers in relation to cardiovascular events and mortality in the community. Arterioscler Thromb Vasc Biol 33: 1728-1733, 2013.
11. van Holten TC,Waanders LF, de Groot PG, Vissers J, Hoefer IE, Pasterkamp G, Prins MW, Roest M: Circulating biomarkers for predicting cardiovascular disease risk; a systematic review and comprehensive overview of meta-analyses. PLoS One 8: e62080, 2013.
12. Shishehbor MH, Oliveira LP, Lauer MS, Sprecher DL, Wolski K, Cho L, Hoogwerf BJ, Hazen SL: Emerging cardiovascular risk factors that account for a significant portion of attributablemortality risk in chronic kidney disease. Am J Cardiol 101: 1741-1746, 2008.
13. Shai I, Schulze MB, Manson JE, Rexrode KM, Stampfer MJ, Mantzoros C, Hu FB: A prospective study of soluble tumor necrosis factor-alpha receptor II (sTNF-RII) and risk of coronary heart disease among women with type 2 diabetes. Diabetes Care 28: 1376-1382, 2005.
14. Jacobsen BK, Eggen AE, Mathiesen EB,Wilsgaard T, Njølstad I: Cohort profile: The Tromso Study. Int J Epidemiol 41: 961-967, 2012.
15. MelsomT,MathisenUD, Eilertsen BA, IngebretsenOC, Jenssen T, Njølstad I, SolbuMD, Toft I, Eriksen BO: Physical exercise, fasting glucose, and renal hyperfiltration in the general population: The Renal Iohexol Clearance Survey in Tromsø 6 (RENIS-T6). Clin J Am Soc Nephrol 7: 1801-1810, 2012.
16. Jacobsson L: A method for the calculation of renal clearance based on a single plasma sample. Clin Physiol 3: 297-305, 1983.
17. Grubb A, Blirup-Jensen S, Lindstrom V, Schmidt C, Althaus H, Zegers I; IFCCWorking Group on Standardisation of Cystatin C (WG-SCC): First certified reference material for cystatin C in human serum ERM-DA471/IFCC. Clin Chem Lab Med 48: 1619-1621, 2010.
18. Solbu MD, Kronborg J, Eriksen BO, Jenssen TG, Toft I: Cardiovascular risk-factors predict progression of urinary albuminexcretion in a general, non-diabetic population: A gender-specific follow-up study. Atherosclerosis 201: 398-406, 2008.
19. MathisenUD,MelsomT, IngebretsenOC, Jenssen TG,Njølstad I, Solbu MD, Toft I, Eriksen BO: Ambulatory blood pressure is associated with measured glomerular filtration rate in the general middle-aged population. J Hypertens 30: 497-504, 2012.
20. Knight EL, Verhave JC, Spiegelman D, Hillege HL, de Zeeuw D, Curhan GC, de Jong PE: Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 65: 1416-1421, 2004.
21. Stevens LA, Schmid CH, Greene T, Li L, Beck GJ, Joffe MM, Froissart M, Kusek JW, Zhang YL, Coresh J, Levey AS: Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int 75: 652-660, 2009.
22. Speeckaert MM, Speeckaert R, Laute M, Vanholder R, Delanghe JR: Tumor necrosis factor receptors: Biology and therapeutic potential in kidney diseases. Am J Nephrol 36:261-270, 2012.
23. Al-Lamki RS, Mayadas TN: TNF receptors: Signaling pathways and contribution to renal dysfunction. Kidney Int 87: 281-296,2015.
24. Gohda T, Niewczas MA, Ficociello LH, Walker WH, Skupien J, Rosetti F, Cullere X, Johnson AC, Crabtree G, Smiles AM, Mayadas TN, Warram JH, Krolewski AS: Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes. J AmSoc Nephrol 23: 516-524, 2012.
25. Danesh J, Lewington S, Thompson SG, Lowe GD, Collins R, Kostis JB,Wilson AC, Folsom AR,Wu K, BenderlyM, Goldbourt U, Willeit J, Kiechl S, Yarnell JW, Sweetnam PM, Elwood PC, CushmanM, Psaty BM, Tracy RP, Tybjaerg-Hansen A, Haverkate F, de Maat MP, Fowkes FG, Lee AJ, Smith FB, Salomaa V, Harald K, Rasi R, Vahtera E, Jousilahti P, Pekkanen J, D'Agostino R, Kannel WB, Wilson PW, Tofler G, Arocha-Pi~nango CL, Rodriguez- Larralde A, Nagy E, Mijares M, Espinosa R, Rodriquez-Roa E, Ryder E, Diez-Ewald MP, Campos G, Fernandez V, Torres E, Marchioli R, Valagussa F, Rosengren A,Wilhelmsen L, Lappas G, Eriksson H, Cremer P, Nagel D, Curb JD, Rodriguez B, Yano K, Salonen JT, Nyyssönen K, Tuomainen TP, Hedblad B, Lind P, Loewel H, Koenig W, Meade TW, Cooper JA, De Stavola B, Knottenbelt C, Miller GJ, Cooper JA, Bauer KA, Rosenberg RD, Sato S, Kitamura A, Naito Y, Palosuo T, Ducimetiere P, Amouyel P, Arveiler D, Evans AE, Ferrieres J, Juhan-Vague I, Bingham A, Schulte H, Assmann G, Cantin B, Lamarche B, Després JP, Dagenais GR, Tunstall-Pedoe H, Woodward M, Ben-Shlomo Y, Davey Smith G, Palmieri V, Yeh JL, Rudnicka A, Ridker P, Rodeghiero F, Tosetto A, Shepherd J, Ford I, Robertson M, Brunner E, Shipley M, Feskens EJ, Kromhout D, Dickinson A, Ireland B, Juzwishin K, Kaptoge S, Lewington S, Memon A, Sarwar N, Walker M, Wheeler J, White I, Wood A; Fibrinogen Studies Collaboration: Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: An individual participant meta-analysis. JAMA 294: 1799-1809,2005.
26. Astor BC, Levey AS, Stevens LA, Van Lente F, Selvin E, Coresh J: Method of glomerular filtration rate estimation affects prediction of mortality risk. J Am Soc Nephrol 20: 2214-2222, 2009.
27. Park M, Yoon E, Lim YH, Kim H, Choi J, Yoon HJ: Renal hyperfiltration as a novel marker of all-cause mortality. J Am Soc Nephrol 26: 1426-1433, 2015.
28. Bird NJ, Peters C, Michell AR, Peters AM: Comparison of GFR measurements assessed from single versus multiple samples. Am J Kidney Dis 54: 278-288, 2009.
29. Stevens LA, Levey AS: Measured GFR as a confirmatory test for estimated GFR. J Am Soc Nephrol 20: 2305-2313, 2009.
30. Isoyama N, Qureshi AR, Avesani CM, Lindholm B, Bàràny P, Heimbü rger O, Cederholm T, Stenvinkel P, Carrero JJ: Comparative associations of muscle mass and muscle strength with mortality in dialysis patients. Clin J Am Soc Nephrol 9: 1720-1728, 2014.